JP2004000251A5 - - Google Patents

Download PDF

Info

Publication number
JP2004000251A5
JP2004000251A5 JP2003271241A JP2003271241A JP2004000251A5 JP 2004000251 A5 JP2004000251 A5 JP 2004000251A5 JP 2003271241 A JP2003271241 A JP 2003271241A JP 2003271241 A JP2003271241 A JP 2003271241A JP 2004000251 A5 JP2004000251 A5 JP 2004000251A5
Authority
JP
Japan
Prior art keywords
amino acid
acid sequence
compound
compound according
human ghrelin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2003271241A
Other languages
English (en)
Japanese (ja)
Other versions
JP4227857B2 (ja
JP2004000251A (ja
Filing date
Publication date
Application filed filed Critical
Priority to JP2003271241A priority Critical patent/JP4227857B2/ja
Priority claimed from JP2003271241A external-priority patent/JP4227857B2/ja
Publication of JP2004000251A publication Critical patent/JP2004000251A/ja
Publication of JP2004000251A5 publication Critical patent/JP2004000251A5/ja
Application granted granted Critical
Publication of JP4227857B2 publication Critical patent/JP4227857B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

JP2003271241A 1999-07-23 2003-07-07 新規ペプチド Expired - Lifetime JP4227857B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2003271241A JP4227857B2 (ja) 1999-07-23 2003-07-07 新規ペプチド

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP21000299 1999-07-23
JP33884199 1999-11-29
JP2000126623 2000-04-26
JP2003271241A JP4227857B2 (ja) 1999-07-23 2003-07-07 新規ペプチド

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2001512558A Division JP3471780B2 (ja) 1999-07-23 2000-07-24 新規ペプチド

Publications (3)

Publication Number Publication Date
JP2004000251A JP2004000251A (ja) 2004-01-08
JP2004000251A5 true JP2004000251A5 (2) 2007-09-06
JP4227857B2 JP4227857B2 (ja) 2009-02-18

Family

ID=27329078

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2001512558A Expired - Lifetime JP3471780B2 (ja) 1999-07-23 2000-07-24 新規ペプチド
JP2003271241A Expired - Lifetime JP4227857B2 (ja) 1999-07-23 2003-07-07 新規ペプチド

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2001512558A Expired - Lifetime JP3471780B2 (ja) 1999-07-23 2000-07-24 新規ペプチド

Country Status (16)

Country Link
US (5) US7385026B1 (2)
EP (3) EP1795598B1 (2)
JP (2) JP3471780B2 (2)
KR (1) KR100827973B1 (2)
CN (2) CN101693736B (2)
AT (2) ATE449174T1 (2)
AU (2) AU784035B2 (2)
BR (2) BR0012688A (2)
CA (2) CA2696819C (2)
CY (2) CY1107724T1 (2)
DE (2) DE60043361D1 (2)
DK (2) DK1795598T3 (2)
ES (3) ES2401939T3 (2)
IL (2) IL147652A0 (2)
PT (2) PT1795598E (2)
WO (1) WO2001007475A1 (2)

Families Citing this family (61)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2401939T3 (es) 1999-07-23 2013-04-25 Kenji Kangawa Nuevos péptidos
EP1232175B1 (en) * 1999-11-22 2009-07-08 ZymoGenetics, Inc. Method of forming a peptide-receptor complex with zsig33 polypeptides.
US6897286B2 (en) 2000-05-11 2005-05-24 Zymogenetics, Inc. Zsig33-like peptides
US7141646B2 (en) 2000-05-12 2006-11-28 Kaneka Corporation Method of purifying vinyl polymer
US6967237B2 (en) 2000-05-30 2005-11-22 Merck & Co., Inc. Ghrelin analogs
CN1443198A (zh) * 2000-07-24 2003-09-17 阿达纳生物科学有限公司 Ghrelin拮抗剂
CN100491395C (zh) * 2002-04-11 2009-05-27 阿斯比奥制药株式会社 修饰肽的制造方法
EP1506786B1 (en) * 2002-05-21 2016-11-23 Daiichi Sankyo Company, Limited Medicinal compositions containing ghrelin
ATE441429T1 (de) * 2002-07-19 2009-09-15 Cytos Biotechnology Ag Ghrelin-träger-konjugate
CA2491946C (en) * 2002-07-23 2013-05-28 Societe De Conseils De Recherches Et D'applications Scientifiques (S.C.R Ghrelin analogs
TWI331922B (en) 2002-08-09 2010-10-21 Ipsen Pharma Sas Growth hormone releasing peptides
KR20050071498A (ko) * 2002-09-18 2005-07-07 상트르 오스피딸리에 드 루니버시떼 드 몬트리알 성장 호르몬 방출 호르몬 유사체
EP1407779A1 (en) * 2002-10-10 2004-04-14 Gastrotech A/S Use of ghrelin for treating low body weight and body fat in gastrectomized individuals
JP4467518B2 (ja) 2003-04-30 2010-05-26 賢治 寒川 肝障害予防治療剤
EP1633397A2 (en) * 2003-06-04 2006-03-15 Eli Lilly And Company Anti-ghrelin fab antibodies
WO2005026211A2 (en) * 2003-09-05 2005-03-24 Eli Lilly And Company Anti-ghrelin antibodies
CN1321131C (zh) * 2003-12-26 2007-06-13 李宁 猪Ghrelin衍生物及其编码基因与应用
CA2553594A1 (en) * 2004-01-20 2005-07-28 Cytos Biotechnology Ag Particle-induced ghrelin immune response
US7026175B2 (en) 2004-03-29 2006-04-11 Applied Materials, Inc. High throughput measurement of via defects in interconnects
WO2005097831A2 (en) * 2004-04-07 2005-10-20 Gastrotech Pharma A/S Uses of isolated binding members capable of binding specifically to secretagogues
WO2005097830A2 (en) * 2004-04-07 2005-10-20 Aditech Pharma Ab Uses of isolated binding members capable of reducing the biological activity of secretagogue compounds
JP2007532495A (ja) * 2004-04-07 2007-11-15 ガストロテック・ファルマ・アクティーゼルスカブ グレリン欠乏を治療するための分泌促進薬の使用
WO2005110463A1 (en) * 2004-05-11 2005-11-24 The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services, National Institutes Of Health Methods of inhibiting proinflammatory cytokine expression using ghrelin
WO2005120484A1 (ja) * 2004-06-09 2005-12-22 Kurume University グレリンの生理学的機能のレギュレーター
US20070237775A1 (en) * 2004-07-14 2007-10-11 Eli Lilly And Company Anti-Ghrelin Antibodies
WO2006045313A2 (en) * 2004-10-27 2006-05-04 Gastrotech Pharma A/S Uses of secretagogues for treatment of organ transplant patients
WO2006045319A2 (en) * 2004-10-27 2006-05-04 Gastrotech Pharma A/S Uses of growth hormone secretagogues in the treatment of individuals suffering from renal and/or liver failure
WO2006058539A2 (en) * 2004-11-30 2006-06-08 Gastrotech Pharma A/S Growth hormone secretagogue receptor 1a ligands
US7803768B2 (en) 2005-02-23 2010-09-28 Kyoto University Method for treatment of hyperglycemia in a subject in need thereof
US7479271B2 (en) 2005-02-23 2009-01-20 Eli Lilly And Company Humanized anti-ghrelin antibodies
RU2427587C2 (ru) * 2005-09-28 2011-08-27 Ипсен Фарма С.А.С. Аналоги грелина
CA2625447C (en) 2005-09-29 2015-06-09 Societe De Conseils De Recherches Et D'applications Scientifiques S.A.S. Compositions and methods for stimulating gastrointestinal motility
WO2007058359A1 (ja) * 2005-11-21 2007-05-24 University Of Miyazaki グレリン及びその誘導体又はGHS-R1aに作用する物質を有効成分とする皮膚修復促進治療剤
JPWO2007058360A1 (ja) * 2005-11-21 2009-05-07 国立大学法人 宮崎大学 デスアシルグレリン及びその誘導体を有効成分とする皮膚修復促進治療剤
WO2007106385A2 (en) * 2006-03-10 2007-09-20 Societe De Conseils De Recherches Et D'applications Scientifiques S.A.S. Use of a ghrelin agonist to improve the catabolic effects of glucocorticoid treatment
NZ571183A (en) 2006-03-13 2010-09-30 Liat Mintz Use of ghrelin splice variant for treating cachexia and/or anorexia and/or anorexia-cachexia and/or malnutrition and/or lipodystrophy and/or muscle wasting and/or appetite stimulation
KR101510082B1 (ko) * 2006-08-01 2015-04-10 더 스크립스 리서치 인스티튜트 비만증을 억제하기 위한 백신 및 방법
JPWO2008018597A1 (ja) * 2006-08-11 2010-01-07 国立大学法人 宮崎大学 デスアシルグレリン及びその誘導体を有効成分とする脊髄神経修復促進治療剤
CA2660517A1 (en) 2006-08-11 2008-02-14 University Of Miyazaki Spinal nerve repair promoting therapeutics containing ghrelin or its derivatives or substances that act on ghs-rla as an active ingredient
US8299022B2 (en) * 2006-09-27 2012-10-30 Ipsen Pharma S.A.S. Analogs of ghrelin substituted at the N-terminal
KR101350251B1 (ko) 2008-05-23 2014-01-14 다이이찌 산쿄 가부시키가이샤 목적 펩타이드의 혈장내 반감기 연장 작용을 가진 펩타이드
ES2610356T3 (es) 2009-02-03 2017-04-27 Amunix Operating Inc. Polipéptidos recombinantes extendidos y composiciones que comprenden los mismos
US9724381B2 (en) 2009-05-12 2017-08-08 The Administrators Of The Tulane Educational Fund Methods of inhibiting the ghrelin/growth hormone secretatogue receptor pathway and uses thereof
US8883721B2 (en) * 2009-05-12 2014-11-11 Mcgill University Methods of inhibiting the ghrelin/growth hormone secretatogue receptor pathway and uses thereof
JP6057314B2 (ja) 2010-01-15 2017-01-11 国立大学法人 宮崎大学 加療中動物の回復促進治療剤
AU2011268256B8 (en) 2010-06-16 2016-12-22 Mcgill University Growth hormone secretatogue receptor antagonists and uses thereof
AU2011361144A1 (en) 2011-03-03 2013-10-03 Daiichi Sankyo Company, Limited Therapeutic agent for hyperthermia
JP5560248B2 (ja) * 2011-09-07 2014-07-23 花王株式会社 ジペプチド誘導体及びその製造方法
JP6355563B2 (ja) 2012-02-27 2018-07-11 アムニクス オペレーティング インコーポレイテッド Xten共役組成物およびそれを製造する方法
AU2013263349B2 (en) 2012-05-17 2016-09-08 Extend Biosciences, Inc Carriers for improved drug delivery
WO2014054798A1 (ja) 2012-10-04 2014-04-10 独立行政法人国立循環器病研究センター 悪性腫瘍転移抑制用医薬
CA2889499C (en) 2012-10-24 2019-09-10 Daiichi Sankyo Company, Limited Growth hormone secretagogue receptor agonists for treating amyotrophic lateral sclerosis
WO2014119753A1 (ja) * 2013-01-31 2014-08-07 学校法人 東京薬科大学 マイオスタチン阻害ペプチド
TWI662967B (zh) * 2013-03-25 2019-06-21 日商志瑞亞新藥工業股份有限公司 食後期之胃運動亢進劑
US9789197B2 (en) 2014-10-22 2017-10-17 Extend Biosciences, Inc. RNAi vitamin D conjugates
US9616109B2 (en) 2014-10-22 2017-04-11 Extend Biosciences, Inc. Insulin vitamin D conjugates
WO2016065042A1 (en) 2014-10-22 2016-04-28 Extend Biosciences, Inc. Therapeutic vitamin d conjugates
CN109879935B (zh) * 2019-03-04 2020-11-20 南京工业大学 一种多肽的液相合成方法
JP7725466B2 (ja) 2019-11-13 2025-08-19 アムニクス ファーマシューティカルズ, インコーポレイテッド バーコード化されたxtenポリペプチドおよびその組成物、ならびにその作製および使用方法
KR20250075704A (ko) 2022-09-30 2025-05-28 익스텐드 바이오사이언시즈, 인크. 장기-지속형 부갑상선 호르몬
CN120818010B (zh) * 2025-09-18 2025-12-05 天津科技大学 一种来自植物乳杆菌属细胞外囊泡的短肽及其应用

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5194596A (en) * 1989-07-27 1993-03-16 California Biotechnology Inc. Production of vascular endothelial cell growth factor
US5350836A (en) * 1989-10-12 1994-09-27 Ohio University Growth hormone antagonists
IL98910A0 (en) * 1990-07-24 1992-07-15 Polygen Holding Corp Polypeptide compounds having growth hormone releasing activity and pharmaceutical compositions containing them
US5663146A (en) * 1991-08-22 1997-09-02 Administrators Of The Tulane Educational Fund Polypeptide analogues having growth hormone releasing activity
DK0635025T3 (da) * 1992-04-07 2003-01-27 Scripps Research Inst Fremgangsmåde til fremstilling af modificerede proteiner
CA2216755A1 (en) * 1995-03-31 1996-10-03 Brian Lee Buckwalter Peptides with growth promotion properties
IL118473A0 (en) 1995-06-02 1996-09-12 Suntory Ltd Staphylococcus aureus V8 protease genes coding therefor and a method for the production thereof
JP3982866B2 (ja) 1996-03-04 2007-09-26 アスビオファーマ株式会社 分泌型Kex2誘導体の製造方法
CA2198966C (en) 1996-03-04 2011-06-21 Yuji Suzuki Method for cleaving chimeric protein using processing enzyme
KR20010005701A (ko) 1997-03-24 2001-01-15 리스 데브라 케이. 모틸린 상동체
CA2328895A1 (en) 1998-06-02 1999-12-09 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
CN1120846C (zh) * 1999-02-13 2003-09-10 中国人民解放军军事医学科学院基础医学研究所 生长激素释放肽及其应用
US6420521B1 (en) * 1999-06-30 2002-07-16 Zymogenetics, Inc. Short gastrointestinal peptides
ES2401939T3 (es) * 1999-07-23 2013-04-25 Kenji Kangawa Nuevos péptidos

Similar Documents

Publication Publication Date Title
JP2004000251A5 (2)
EP2071028A3 (en) HLA-DR-binding antigen peptide derived from WT1
WO2004043382A3 (en) Enhanced variants of erythropoietin and methods of use
JP2006514820A5 (2)
JP2008541776A5 (2)
WO2006131749A3 (en) Scaffold
JP2006503088A5 (2)
JP2949129B2 (ja) 胃腸運動刺激活性を有するモチリン類似ポリペプチド
RU2002135669A (ru) Олигопептиды
JP2003334088A5 (2)
AU2865801A (en) Therapeutic peptides
JP2002534996A5 (2)
JPH051798B2 (2)
EP1842911A4 (en) HLA BINDING PEPTIDES, FOR THOSE CODING DNA FRAGMENTS AND RECOMBINANT VECTORS
EP2261332A3 (en) Libraries of recombinant chimeric proteins
JP2006510360A5 (2)
EP1757687A4 (en) HLA BINDING PEPTIDE, PRE-STEP, DNA DOMAGING AND RECOMBINANT VECTOR
Chorev et al. Biological activity of parathyroid hormone antagonists substituted at position 13
WO2001087932A3 (en) Seven transmembrane proteins and polynucleotides encoding the same
EP1354893A3 (en) Physiologically active complex
WO2003064446A3 (en) Plasma protein-binding peptides from bacterial curli
DE60325227D1 (2)
WO2004050703A8 (en) Splice variant of the human pituitary growth hormone
WO2001094417A3 (en) Novel human seven transmembrane proteins and polynucleotides encoding the same
JP2003144177A5 (2)